CHMP5 and COVID-19: As at the time of recruitment (May, 2020 to February, 2021), the spike protein sequence of the SARS-CoV-2 variant prevalent in Portugal (54) coincided with the spike sequence used both in mRNA COVID-19 vaccines and in our in vitro neutralization assay.